"10.1371_journal.pone.0103280","plos one","2014-08-20T00:00:00Z","Kenny Shum; Peter Alperin; Svetlana Shalnova; Sergey Boytsov; Anna Kontsevaya; Alexey Vigdorchik; Adam Guetz; Jennifer Eriksson; David Hughes","Archimedes, San Francisco, California, United States of America; National Research Center for Preventive Medicine, Moscow, Russia; Novartis Pharma LLC, Moscow, Russia; OptumInsight Life Sciences, Stockholm, Sweden; Department of Healthcare Systems, Novartis International AG, Basel, Switzerland","Conceived and designed the experiments: KS PA AV AG JE DH. Performed the experiments: KS PA SS SB AK AV AG JE DH. Analyzed the data: KS PA SS SB AK AV AG JE DH. Contributed reagents/materials/analysis tools: KS PA AG. Wrote the paper: KS PA SS SB AK AV AG JE DH.","The authors have read the journals policy and have the following conflicts to declare: Kenny Shum is an employee of Evidera Inc. (formerly Archimedes Inc.), and the work on the manuscript was funded by Novartis when he was employee of Archimedes Inc. Peter Alperin was an employee of Archimedes Inc., at the time of writing this paper. Svetlana Shalnova has no conflict of interest to declare. Sergey Boytsov has no conflict of interest to declare. Anna Kontsevaya has received travel grants from AstraZeneca, KRKA, Medtronic, Pfizer, and Pharmstandart; and Research grants from KRKA, Medtronic, Pfizer, and Stentex. Alexey Vigdorchik is a full-time employee (Medical Project Manager) of Novartis Pharma LLC, Moscow. Adam Guetz was an employee of Archimedes Inc., at the time of writing this paper. Jennifer Eriksson is employed by OptumInsight, a research organization acting as consultants to the pharmaceutical industry. David Hughes is a full-time employee of Novartis International AG, Switzerland. The author disclosure information does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","08","Kenny Shum","KS",9,TRUE,6,9,9,9,TRUE,TRUE,FALSE,0,NA,FALSE
